However, no published research directly compares continuous versus cycled protocols
Any mention of published preclinical data, mechanisms of action, or experimental outcomes is provided exclusively for scientific context and literature review
Nodules are expected with BPC-157: small subcutaneous bumps at the injection site are a normal depot response, not infection, and resolve within two to three days without intervention
Research on humans is still underway, but the results so far are promising
TB500 promotes cell migration, cytoskeletal reorganization, and new blood vessel formation in preclinical modelskey steps in early wound healing and longterm tissue remodeling
The injection is usually given intramuscularly or intravenously by a doctor or trained healthcare professional